Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes.
about
Is A1C Variability an Independent Predictor for the Progression of Atherosclerosis in Type 2 Diabetic Patients?Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analysesComparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone.Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace study.Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetesA review of nateglinide in the management of patients with type 2 diabetes.Insulin aspart: a review.Pathogenesis and treatment of diabetic vascular disease - illustrated by two cases.Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study.Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.Altered disease course after initiation of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes (ROSSO 3)Randomized forced titration to different doses of technosphere insulin demonstrates reduction in postprandial glucose excursions and hemoglobin A1c in patients with type 2 diabetes.Inhaled Technosphere insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetes.Serum level of Interleukin-8 in subjects with diabetes, diabetes plus oral lichen planus, and oral lichen planus: A biochemical study.HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics.The rise and fall of HbA(1c) as a risk marker for diabetes complications.Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study.Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
P2860
Q33969587-B0DD76E5-A2EA-4A32-A7F0-6E176B5C2D1CQ34281482-26277D19-3539-442C-BB80-465E0313C7A1Q35038326-FFD893B1-2FE8-4C6D-87F1-61F241E00725Q35337177-F35CBE89-C558-4A28-BF17-EA5908A2208AQ36012896-2AB15E3A-6A31-4AB8-A946-ADF425912AB1Q36596836-855DD852-909F-4A54-8CCA-B68A152AD3B2Q36609772-7290FA04-4A6A-454B-8810-6718E9075D72Q36623110-0DFB21A4-60FD-4FE2-B545-C3FD230A03FEQ36756637-AE37D703-4D7C-42BB-B36C-D873D2F68016Q37022639-FEB7E052-C686-4A7B-AB9B-512F47B721FEQ37113138-0687A0E4-6EE7-4036-8C2A-119B67AF6924Q37403957-0DF06B1C-7CEF-410A-94D5-007C347C1AF8Q37404094-10911621-7A3C-4F8D-AEB5-0019EF79AABFQ37407977-8278C9B9-E83E-4163-8571-F05EB6D0FBFFQ39178821-7AC2EFF5-F5E3-4124-B387-170ECB298E48Q40364101-A3D51FE9-A672-4A4F-A588-41436CAFD5C2Q45787804-3CA9F9A6-0F38-4956-B780-702732A4AF76Q50179675-EDAB14BD-A0C4-404A-BD65-3726D1B7492AQ51317229-DDA5EAAB-2F41-4266-A47A-C26AB7BFCC7DQ51491998-01E17105-7B69-435D-9C2A-6632EBCE4DBF
P2860
Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Contributions of basal and pos ...... n people with type 2 diabetes.
@ast
Contributions of basal and pos ...... n people with type 2 diabetes.
@en
type
label
Contributions of basal and pos ...... n people with type 2 diabetes.
@ast
Contributions of basal and pos ...... n people with type 2 diabetes.
@en
prefLabel
Contributions of basal and pos ...... n people with type 2 diabetes.
@ast
Contributions of basal and pos ...... n people with type 2 diabetes.
@en
P356
P1476
Contributions of basal and pos ...... n people with type 2 diabetes.
@en
P2093
Philip Home
P304
P356
10.1185/030079905X49662
P407
P577
2005-07-01T00:00:00Z